Expertise in
4
conditions

Dr. James Wheeler

Radiation Oncology
Goshen Center For Cancer Care
200 High Park Ave, 
Goshen, IN 
37 Years of Experience
Expertise in
4
conditions
Goshen Center For Cancer Care
200 High Park Ave, 
Goshen, IN 

Overview

James Wheeler is a Radiation Oncologist practicing medicine in Goshen, Indiana. He has been practicing medicine for over 37 years.

Dr. Wheeler is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 6 clinical trials.

Graduate Institution

University Of Kansas School Of Med (Kc/wich/sal), 1989

Specialties

Radiation Oncology

Licenses

Radiology in IN

Hospital Affiliations

Goshen Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO

Locations

Goshen Center for Cancer Care
200 High Park Ave, Goshen, IN 46526

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Procedure
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: March 02, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 23, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

4 Total Publications

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 17, 2019
Similar Doctors
Expertise in
10
conditions
Dr. Houman Vaghefi
Radiation Oncology
Expertise in
10
conditions
Dr. Houman Vaghefi
Radiation Oncology

Goshen Center For Cancer Care

200 High Park Ave, 
Goshen, IN 
 (0.1 miles away)
574-364-2888
Languages Spoken:
English
See accepted insurances

Houman Vaghefi is a Radiation Oncologist practicing medicine in Goshen, Indiana. Dr. Vaghefi is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Prostate Cancer, and Familial Prostate Cancer.

Expertise in
42
conditions
Dr. Brian Chang
Radiation Oncology
Expertise in
42
conditions
Dr. Brian Chang
Radiation Oncology

Fort Wayne Medical Oncology And Hematology Inc.

516 E Maumee St, 
Angola, IN 
 (43.5 miles away)
866-624-2120
Languages Spoken:
English
See accepted insurances

Brian Chang is a Radiation Oncologist practicing medicine in Angola, Indiana. Dr. Chang is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Laryngeal Cancer, and Posterior Fossa Tumor.

Expertise in
17
conditions
Dr. Peter A. Paximadis
Radiation Oncology
Expertise in
17
conditions
Dr. Peter A. Paximadis
Radiation Oncology

Corewell Health Lakeland Hospitals Radiation Oncology St Joseph

1234 Napier Avenue, 
Saint Joseph, MI 
 (49.3 miles away)
269-983-8888
Experience:
18+ years
Languages Spoken:
English
See accepted insurances

Peter Paximadis is a Radiation Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 18 years. Dr. Paximadis is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, and Familial Prostate Cancer. Dr. Paximadis is board certified in American Board Of Radiology.

Frequently Asked Questions about Dr. James Wheeler

How do I make an appointment with Dr. James Wheeler?

You can book an appointment with Dr. James Wheeler by calling their office at 574-364-2888. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James Wheeler a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James Wheeler is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James Wheeler specialize in?

While Dr. James Wheeler is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. James Wheeler participate in research or clinical trials?

Yes. Dr. James Wheeler has published 4 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. James Wheeler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James Wheeler accept my insurance?

Dr. James Wheeler accepts most major insurance plans, including CareSource. We recommend calling the office directly at 574-364-2888 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wheeler's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile